Matthew H Hayn
Overview
Explore the profile of Matthew H Hayn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
504
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pagadala M, Linscott J, Talwar J, Seibert T, Rose B, Lynch J, et al.
BMC Cancer
. 2022 Dec;
22(1):1289.
PMID: 36494783
Background: Prostate cancer (PrCa) is one of the most genetically driven solid cancers with heritability estimates as high as 57%. Men of African ancestry are at an increased risk of...
2.
Hansen N, Linscott J, Hayn M, Ryan S, Sammon J
J Urol
. 2022 Oct;
209(1):161-169.
PMID: 36250952
Purpose: Immigrants constitute 14% of the U.S. population, and this group is especially vulnerable to poor health care access. Prior research demonstrates U.S. immigrants have low rates of guideline-concordant breast...
3.
Daly W, Linscott J, Han P, Hayn M, Hansen M, Ryan S, et al.
J Urol
. 2021 Mar;
205(6):1646-1647.
PMID: 33734857
No abstract available.
4.
Daly W, Linscott J, Han P, Hayn M, Hansen M, Ryan S, et al.
J Urol
. 2021 Feb;
205(6):1641-1647.
PMID: 33530748
Purpose: Medicaid expansion under the Patient Protection and Affordable Care Act occurred almost concurrently with 2012 U.S. Preventive Services Task Force recommendations against prostate specific antigen screening. Here the relative...
5.
Linscott J, Rutan M, Han P, Hansen M, Hayn M, Ryan S, et al.
J Urol
. 2020 Jun;
204(3):569.
PMID: 32574086
No abstract available.
6.
Linscott J, Rutan M, Han P, Hansen M, Hayn M, Ryan S, et al.
J Urol
. 2020 Apr;
204(3):564-569.
PMID: 32267200
Purpose: Implementation of survivorship care plans has been emphasized as a key component to improving care for cancer survivors. Our objective was to determine the prevalence of survivorship care plan...
7.
Tan W, Trinh Q, Hayn M, Marchese M, Lipsitz S, Nabi J, et al.
Urol Oncol
. 2019 Dec;
38(3):74.e13-74.e20.
PMID: 31864937
Objectives: Early surgical resection remains the recommended treatment option for most small renal mass (≤4 cm). We examined the long-term overall survival (OS) of patients managed with delayed and immediate...
8.
Eggener S, Badani K, Barocas D, Barrisford G, Cheng J, Chin A, et al.
J Urol
. 2015 Apr;
194(3):626-34.
PMID: 25849602
Purpose: Gleason 6 (3+3) is the most commonly diagnosed prostate cancer among men with prostate specific antigen screening, the most histologically well differentiated and is associated with the most favorable...
9.
OMalley R, Hayn M, Brewer K, Underwood 3rd W, Hellenthal N, Kim H, et al.
World J Urol
. 2015 Mar;
33(11):1807-14.
PMID: 25805189
Purpose: Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma is unclear. To assess whether PN provides adequate cancer control in high-risk disease (HRD), survival outcomes were compared...
10.
Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients
Sammon J, McKay R, Kim S, Sood A, Sukumar S, Hayn M, et al.
Urology
. 2015 Jan;
85(2):343-9.
PMID: 25623683
Objective: To examine the rates of hospitalization in patients with metastatic prostate cancer (mCaP), as well as the effect of hospice utilization on the cost patterns of mCaP. Over the...